XALLOY Advanced Materials Corporation

XALLOY Advanced Materials Corporation

TTPEX:7918
629.00
TWD
-3.00
(-0.47%)
52.80BMarket Cap
XALLOY Advanced Materials Corporation
TPEX:7918
(Taipei Exchange)

Recent

price

629.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2024
2025
TWD
- -
45.93
Revenue per Share
- -
5.65
Basic EPS, GAAP
- -
9.21
Free Cash Flow per Basic Share
- -
- -
Dividend per Share
- -
26.52
Book Value per Share
- -
26.31
Tangible Book Value per Share
10
10
Basic Weighted Avg Shares
- -
444
Sales/Revenue/Turnover
- -
15.87
Operating Margin (%)
- -
30
Depreciation Expense
- -
55
Net Income, GAAP
- -
20
Effective Tax Rate (%)
- -
12.3
Profit Margin (%)
- -
529
Working Capital
- -
286
LT Debt
- -
1,143
Total Equity
- -
4.18
Return on Invested Capital (%)
- -
4.59
Return on Capital (%)
- -
9.55
Return on Common Equity (%)

Capital Structure

TWD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

TWD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

TWD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
444
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
5.65
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
XALLOY Advanced Materials Corporation is a Taiwan-based advanced materials company engaged in the research, development, custom formulation, manufacturing, and commercial distribution of high-performance specialty alloys, advanced metal powders, and precision engineered metallurgical components. The company operates across three primary business segments: Specialty Alloy Materials, Additive Manufacturing Powders, and Precision Engineered Components. Its product portfolio comprises titanium and titanium alloys, including biomedical-grade titanium bars, dental discs, aerospace-grade sheets, and custom forged billets; nickel-base and cobalt-base superalloys engineered for high-temperature turbine parts, chemical processing equipment, and power generation systems; gas-atomized spherical metal powders formulated for laser powder bed fusion and directed energy deposition industrial 3D printing applications; high-purity copper and aluminum alloys developed for thermal management and semiconductor packaging; refractory and specialty metal alloys used in high-vacuum environments and electronic sputtering targets; and precision casting materials and custom-machined metallurgical components. The company caters to diverse high-technology and mission-critical industries, including aerospace and defense, semiconductor manufacturing equipment, biomedical devices and orthopedic implants, renewable energy, and precision automotive engineering. Founded in 2021 and headquartered in Tainan, Taiwan, XALLOY Advanced Materials Corporation primarily serves domestic clients across Taiwan while exporting its specialized alloy products to industrial markets throughout the Asia-Pacific region, North America, and Europe. In recent operational and strategic developments, the company achieved registration on the Taipei Exchange under ticker symbol 7918 to support its ongoing capital expansion programs. Over the past two years, XALLOY has expanded its high-purity vacuum induction melting and inert gas atomization production capacity, launched new grades of spherical titanium and high-entropy alloy powders engineered specifically for advanced aerospace additive manufacturing, entered strategic technical collaborations with semiconductor equipment manufacturers to develop next-generation thermal dissipation materials, and secured ISO 13485 medical device quality management system certification to accelerate its penetration into international biomedical implant supply chains.